Celldex to Report Fourth Quarter and Year-End 2017 Business/Financial Results and Present at Upcoming Investor Conference
March 02 2018 - 3:15PM
Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today upcoming
investor events in March.
2017 Year-End Results and Conference
Call/Webcast
Celldex will release fourth quarter and year-end 2017 financial
results on Wednesday, March 7, 2018 after the U.S. financial
markets close. Celldex executives will host a conference call at
4:30 p.m. EST on the same day to discuss 2017 financial and
business results and to provide an update on upcoming milestones
for 2018.
The conference call and presentation will be webcast live over
the internet and can be accessed by going to the "Events &
Presentations" page under the "Investors & Media" section of
the Celldex Therapeutics website at www.celldex.com. The call can
also be accessed by dialing (866) 743-9666 (within the United
States) or (760) 298-5103 (outside the United States). The passcode
is 8296067.
A replay of the call will be available approximately two hours
after the live call concludes through March 15, 2018. To access the
replay, dial (855) 859-2056 (within the United States) or (404)
537-3406 (outside the United States). The passcode is 8296067. The
webcast will also be archived on the Company's website.
Upcoming Investor Conference
Anthony Marucci, Co-founder, President and Chief Executive
Officer, will present a corporate overview at the Cowen and Company
38th Annual Health Care Conference in Boston on Monday, March 12,
2018 at 2:10 p.m. EDT.
A live webcast of the presentation will be available on the
"Events & Presentations" page of the "Investors & Media"
section of the Celldex website. A replay will be available for
seven days following the event.
About Celldex Therapeutics, Inc.
Celldex is developing targeted therapeutics to address
devastating diseases for which available treatments are inadequate.
Our pipeline includes antibodies, antibody-drug conjugates and
other protein-based therapeutics derived from a broad set of
complementary technologies which have the ability to engage the
human immune system and/or directly inhibit tumors to treat
specific types of cancer or other diseases. Visit
www.celldex.com.
Contact
Sarah CavanaughSenior Vice President, Corporate Affairs &
Administration(781) 433-3161scavanaugh@celldex.com
Charles LilesAssociate
Director, Investor Relations & Corp Communications(617)
383-3433cliles@celldex.com
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Oct 2023 to Oct 2024